Effect of immunotherapy and time-of-day infusion chronomodulation on survival in advanced cancers.

Authors

null

Blessie Elizabeth Nelson

University of Texas MD Anderson Cancer Center, Houston, TX

Blessie Elizabeth Nelson , Clark Andersen , Ying Yuan , David S. Hong , Aung Naing , Daniel D. Karp , Timothy A. Yap , Jordi Rodon Ahnert , Erick Campbell , Apostolia Maria Tsimberidou , Ecaterina Elena Dumbrava , Siqing Fu , Sarina Anne Piha-Paul , Shubham Pant , George R. Blumenschein , Mehmet Altan , Hussein A. Tawbi , Nizar M. Tannir , Funda Meric-Bernstam , Vivek Subbiah

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Care Delivery and Regulatory Policy

Track

Care Delivery and Quality Care

Sub Track

Practice Management

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 1588)

DOI

10.1200/JCO.2022.40.16_suppl.1588

Abstract #

1588

Poster Bd #

180

Abstract Disclosures

Similar Posters

First Author: Glenn J. Hanna

Poster

2021 Gastrointestinal Cancers Symposium

Response to PD-1 and PD-L1 based immunotherapy in MSS advanced colorectal cancer is impacted by metastatic disease sites.

Response to PD-1 and PD-L1 based immunotherapy in MSS advanced colorectal cancer is impacted by metastatic disease sites.

First Author: Marwan Fakih

First Author: Antoine Italiano

First Author: Fang Wu